Humacyte, Inc. (NASDAQ:HUMA) Receives $13.71 Consensus Price Target from Analysts
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) has received a consensus rating of “Buy” from the eight ratings firms that are ...
North Carolina biotech weighs demand as breakthrough treatment hits market
Humacyte has priced the product at $29,500 per unit. This is more expensive than the synthetic vessels already on the market.
Zacks.com on MSN4d
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
Humacyte, Inc. (HUMA) closed the most recent trading day at $3.96, moving -1.25% from the previous trading session.
Nasdaq4d
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
Humacyte, Inc. (HUMA) ended the recent trading session at $3.96, demonstrating a -1.25% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of ...